BY Sarah Bronson

Two new clinical trials at MD Anderson are taking aim at mantle cell lymphoma – a rare form of non-Hodgkin’s lymphoma.

Most mantle cell lymphoma trials test new treatments on patients with relapsed disease, but MD Anderson’s trials are focusing on patients who are newly diagnosed.

“The first therapy is the most important,” said Michael Wang, M.D., professor of Lymphoma and Myeloma and the trial’s principal investigator....